March 11 (Reuters) - Ironwood Pharmaceuticals Inc IRWD.O:
IRONWOOD PHARMACEUTICALS INC - SATISFIES LIQUIDITY CONDITIONS IN CREDIT AGREEMENT ON MARCH 10, 2026 - SEC FILING
IRONWOOD PHARMACEUTICALS INC - MATURITY DATE FOR REVOLVING CREDIT FACILITY REMAINS DECEMBER 31, 2028 - SEC FILING